Literature DB >> 8435176

Autoimmune exocrinopathy presenting as recurrent parotitis of childhood.

M Hearth-Holmes1, B A Baethge, F Abreo, R E Wolf.   

Abstract

OBJECTIVE: To describe a case of autoimmune exocrinopathy in a child at the age of 3 months who presented with the original diagnosis of recurrent parotitis.
DESIGN: This a case report of a 9-year-old girl with recurrent parotitis who was later found to have Sjögren's syndrome. The literature relating to primary Sjögren's syndrome in the pediatric population is reviewed.
SETTING: The patient was seen in the rheumatology and otolaryngology clinics at a university medical center.
INTERVENTIONS: This study did not address therapy. MAIN OUTCOME MEASURE: Diagnosis of Sjögren's syndrome.
RESULTS: The patient had xerostomia, an abnormal result of a salivary gland biopsy, SSA and SSB antibodies, and the histocompatibility antigens HLA-B8 and HLA-DR3 that are associated with Sjögren's syndrome.
CONCLUSION: Primary Sjögren's syndrome should be considered in cases of recurrent parotitis of childhood. More studies are needed to assess the natural history of autoimmune exocrinopathy in children.

Entities:  

Mesh:

Year:  1993        PMID: 8435176     DOI: 10.1001/archotol.1993.01880150103015

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Autosomal dominant juvenile recurrent parotitis.

Authors:  E Reid; F Douglas; Y Crow; A Hollman; J Gibson
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

Review 2.  Diseases of the salivary glands in infants and adolescents.

Authors:  Maik Ellies; Rainer Laskawi
Journal:  Head Face Med       Date:  2010-02-15       Impact factor: 2.151

3.  Primary Sjögren syndrome in the paediatric age: a multicentre survey.

Authors:  Rolando Cimaz; Annachiara Casadei; Carlos Rose; Jirina Bartunkova; Anna Sediva; Fernanda Falcini; Paolo Picco; Marco Taglietti; Francesco Zulian; Rebecca Ten Cate; Flavio R Sztajnbok; Paraskevi V Voulgari; Alexandros A Drosos
Journal:  Eur J Pediatr       Date:  2003-07-29       Impact factor: 3.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.